LIGAND PHARMACEUTICALS INCORPORATED Additional Paid in Capital
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) had Additional Paid in Capital of $379.77 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-08-07
- 2026-06-30: Additional Paid in Capital $379.77M.
- 2026-03-31: Additional Paid in Capital $397.17M.
- 2025-12-31: Additional Paid in Capital $400.65M.
- 2025-09-30: Additional Paid in Capital $362.61M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2026-06-30 | $379.77M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $397.17M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $400.65M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $362.61M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $358.63M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $340.54M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $337.38M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $309.34M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $238.87M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $218.26M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $198.70M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $183.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $170.74M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $154.42M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $147.59M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $348.99M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $335.47M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $325.37M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $372.97M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $358.42M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $346.58M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $336.62M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $318.36M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $313.06M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $304.40M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $295.94M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $367.33M 10-K · filed 2021-02-24 | |
| 2019-09-30 | $444.59M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $619.25M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $643.32M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $791.11M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $883.48M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $874.18M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $808.76M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $798.21M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $793.72M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $784.38M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $777.10M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $769.65M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $762.58M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $755.05M 10-Q · filed 2016-11-14 | $789.32M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $783.89M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $661.85M 10-K · filed 2017-02-28 | $701.48M 10-K · filed 2016-02-26 |
| 2015-09-30 | $697.06M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $692.76M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $684.36M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $680.66M 10-K · filed 2016-11-14 | $718.02M 10-K · filed 2014-12-01 |
| 2014-09-30 | $707.18M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $726.76M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $723.28M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $718.02M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $758.08M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $755.30M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $752.95M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $751.50M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $747.32M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $743.37M 10-Q/A · filed 2012-11-14 | |
| 2012-03-31 | $741.89M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $732.68M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $731.90M 10-Q/A · filed 2012-02-10 | |
| 2011-06-30 | $730.97M 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $729.27M 10-K/A · filed 2012-11-14 |